These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26274787)

  • 1. Oxidative stress in dogs with multicentric lymphoma: Effect of chemotherapy on oxidative and antioxidant biomarkers.
    Bottari NB; Munhoz TD; Torbitz VD; Tonin AA; Anai LA; Semolin LM; Jark PC; Bollick YS; Moresco RN; França RT; Lopes ST; Stefani LM; Tinucci-Costa M; Da Silva AS
    Redox Rep; 2015; 20(6):267-74. PubMed ID: 26274787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
    J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
    Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
    Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA profiling in canine multicentric lymphoma.
    Craig KKL; Wood GA; Keller SM; Mutsaers AJ; Wood RD
    PLoS One; 2019; 14(12):e0226357. PubMed ID: 31826004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant status and biomarkers of oxidative stress in dogs with lymphoma.
    Winter JL; Barber LG; Freeman L; Griessmayr PC; Milbury PE; Blumberg JB
    J Vet Intern Med; 2009; 23(2):311-6. PubMed ID: 19210312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol.
    Simon D; Nolte I; Eberle N; Abbrederis N; Killich M; Hirschberger J
    J Vet Intern Med; 2006; 20(4):948-54. PubMed ID: 16955821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of COAP and UW-19 protocols for dogs with multicentric lymphoma.
    Hosoya K; Kisseberth WC; Lord LK; Alvarez FJ; Lara-Garcia A; Kosarek CE; London CA; Couto CG
    J Vet Intern Med; 2007; 21(6):1355-63. PubMed ID: 18196747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide and prednisolone for chemotherapy naïve B cell multicentric lymphoma in dogs: 32 cases (2017-2021).
    Todd J; Thomas P; Nguyen S
    J Small Anim Pract; 2022 Jan; 63(1):52-55. PubMed ID: 34647324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma.
    Lurie DM; Gordon IK; Théon AP; Rodriguez CO; Suter SE; Kent MS
    J Vet Intern Med; 2009; 23(5):1064-70. PubMed ID: 19627472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.
    Zemann BI; Moore AS; Rand WM; Mason G; Ruslander DM; Frimberger AE; Wood CA; L'Heureux DA; Gliatto J; Cotter SM
    J Vet Intern Med; 1998; 12(6):465-70. PubMed ID: 9857340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum C-reactive protein concentrations in dogs with multicentric lymphoma undergoing chemotherapy.
    Merlo A; Rezende BC; Franchini ML; Simões DM; Lucas SR
    J Am Vet Med Assoc; 2007 Feb; 230(4):522-6. PubMed ID: 17302548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.
    Wang SL; Lee JJ; Liao AT
    Can Vet J; 2016 Mar; 57(3):271-6. PubMed ID: 26933263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of temporal association of relapse of canine multicentric lymphoma with components of the CHOP protocol: Is cyclophosphamide the weakest link?
    Wang SL; Lee JJ; Liao AT
    Vet J; 2016 Jul; 213():87-9. PubMed ID: 27240922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in biomarkers of redox status in serum and saliva of dogs with hypothyroidism.
    Arostegui LGG; Prieto AM; Marín LP; López GG; Tvarijonaviciute A; Madrigal JJC; Rubio CP
    BMC Vet Res; 2023 Feb; 19(1):33. PubMed ID: 36732758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of resveratrol on glycation and oxidation products in plasma and liver of chronic methylglyoxal-treated rats.
    Yılmaz Z; Kalaz EB; Aydın AF; Olgaç V; Doğru-Abbasoğlu S; Uysal M; Koçak-Toker N
    Pharmacol Rep; 2018 Jun; 70(3):584-590. PubMed ID: 29679882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol.
    Curran K; Thamm DH
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1():147-55. PubMed ID: 26279153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid A is not a marker for relapse of multicentric lymphoma in dogs.
    Merlo A; Rezende BC; Franchini ML; Monteiro PR; Lucas SR
    Vet Clin Pathol; 2008 Mar; 37(1):79-85. PubMed ID: 18366549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced neutropenia is associated with prolonged remission duration and survival time in canine lymphoma.
    Wang SL; Lee JJ; Liao AT
    Vet J; 2015 Jul; 205(1):69-73. PubMed ID: 26004824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
    Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
    Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
    Hiddemann W; Kneba M; Dreyling M; Schmitz N; Lengfelder E; Schmits R; Reiser M; Metzner B; Harder H; Hegewisch-Becker S; Fischer T; Kropff M; Reis HE; Freund M; Wörmann B; Fuchs R; Planker M; Schimke J; Eimermacher H; Trümper L; Aldaoud A; Parwaresch R; Unterhalt M
    Blood; 2005 Dec; 106(12):3725-32. PubMed ID: 16123223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.